醋酸甲羟孕酮长效注射剂和庚酸炔诺酮的初步药代动力学和药效学评价。 - Suppr

Suppr

超能文献

A preliminary pharmacokinetic and pharmacodynamic evaluation of depot-medroxyprogesterone acetate and norethisterone oenanthate.

作者信息

Fotherby K, Saxena B N, Shrimanker K, Hingorani V, Takker D, Diczfalusy E, Landgren B M

出版信息

Fertil Steril. 1980 Aug;34(2):131-9. doi: 10.1016/s0015-0282(16)44895-8.

DOI:10.1016/s0015-0282(16)44895-8

PMID:7409232

Abstract

摘要

相似文献

A preliminary pharmacokinetic and pharmacodynamic evaluation of depot-medroxyprogesterone acetate and norethisterone oenanthate.醋酸甲羟孕酮长效注射剂和庚酸炔诺酮的初步药代动力学和药效学评价。

Fertil Steril. 1980 Aug;34(2):131-9. doi: 10.1016/s0015-0282(16)44895-8.

Metabolic parameter, bleeding, and weight changes in U.S. women using progestin only contraceptives.美国使用仅含孕激素避孕药的女性的代谢参数、出血及体重变化。

Contraception. 1995 Mar;51(3):149-53. doi: 10.1016/0010-7824(95)00011-x.

A randomized, single blind comparative trial of norethindrone enanthate and depo-medroxyprogesterone acetate in Bangladesh.孟加拉国庚酸炔诺酮与醋酸甲羟孕酮的随机单盲对照试验。

Contraception. 1980 Mar;21(3):207-15. doi: 10.1016/0010-7824(80)90001-3.

Multinational comparative clinical evaluation of two long-acting injectable contraceptive steroids: noresthisterone oenanthate and medroxyprogesterone acetate. 2. Bleeding patterns and side effects.两种长效注射用避孕甾体激素的多国比较临床评估：庚酸炔诺酮和醋酸甲羟孕酮。2. 出血模式与副作用。

Contraception. 1978 May;17(5):395-406.

Pharmacokinetic study of different doses of Depo Provera.不同剂量醋酸甲羟孕酮的药代动力学研究。

Contraception. 1980 Nov;22(5):527-36. doi: 10.1016/0010-7824(80)90105-5.

Once-a-month estrogen/progestogen injectables.每月一次的雌激素/孕激素注射剂。

Entre Nous Cph Den. 1991 Dec(19):15.

Pharmacokinetics and pharmacodynamics of sustained release systems.缓释系统的药代动力学和药效学

J Steroid Biochem. 1979 Jul;11(1B):457-9. doi: 10.1016/0022-4731(79)90067-0.

A comparative study of one-year weight gain among users of medroxyprogesterone acetate, levonorgestrel implants, and oral contraceptives.醋酸甲羟孕酮、左炔诺孕酮植入剂和口服避孕药使用者一年体重增加情况的比较研究。

Contraception. 1995 Oct;52(4):215-9. doi: 10.1016/0010-7824(95)00189-h.

Timing of onset of contraceptive effectiveness in Depo-Provera users. II. Effects on ovarian function.使用醋酸甲羟孕酮避孕者避孕效果开始的时间。II. 对卵巢功能的影响。

Fertil Steril. 1998 Nov;70(5):817-20. doi: 10.1016/s0015-0282(98)00309-4.

A comparative study on the return to ovulation following chronic use of once-a-month injectable contraceptives.长期使用每月注射一次的避孕药后排卵恢复情况的对比研究。

Contraception. 1995 May;51(5):307-11. doi: 10.1016/0010-7824(95)00080-t.

引用本文的文献

U.S. Selected Practice Recommendations for Contraceptive Use, 2024.美国 2024 年避孕方法选择实践推荐

MMWR Recomm Rep. 2024 Aug 8;73(3):1-77. doi: 10.15585/mmwr.rr7303a1.

Effects of injectable contraception with depot medroxyprogesterone acetate or norethisterone enanthate on estradiol levels and menstrual, psychological and behavioral measures relevant to HIV risk: The WHICH randomized trial.注射用醋酸甲羟孕酮或庚酸炔诺酮避孕对雌二醇水平及与艾滋病毒风险相关的月经、心理和行为措施的影响：WHICH 随机试验。

PLoS One. 2024 Mar 26;19(3):e0295764. doi: 10.1371/journal.pone.0295764. eCollection 2024.

Misreporting contraceptive use and the association of peak study progestin levels with weight and BMI among women randomized to the progestin-only injectable contraceptives DMPA-IM and NET-EN.错误报告避孕方法的使用情况以及在接受孕激素仅注射避孕药 DMPA-IM 和 NET-EN 随机分组的女性中，研究中孕激素水平峰值与体重和 BMI 的关系。

PLoS One. 2023 Dec 22;18(12):e0295959. doi: 10.1371/journal.pone.0295959. eCollection 2023.

Variability and quantification of serum medroxyprogesterone acetate levels.血清醋酸甲羟孕酮水平的变异性和定量。

Steroids. 2022 Nov;187:109100. doi: 10.1016/j.steroids.2022.109100. Epub 2022 Aug 12.

Initiating Intramuscular Depot Medroxyprogesterone Acetate Increases Frequencies of Th17-like Human Immunodeficiency Virus Target Cells in the Genital Tract of Women in South Africa: A Randomized Trial.在南非，启动肌肉内注射 depot 醋酸甲羟孕酮会增加生殖道中类似于 Th17 的人类免疫缺陷病毒靶细胞的频率：一项随机试验。

Clin Infect Dis. 2022 Nov 30;75(11):2000-2011. doi: 10.1093/cid/ciac284.

Pharmacokinetics, metabolism and serum concentrations of progestins used in contraception.避孕用孕激素的药代动力学、代谢和血清浓度。

Pharmacol Ther. 2021 Jun;222:107789. doi: 10.1016/j.pharmthera.2020.107789. Epub 2020 Dec 13.

The contraceptive medroxyprogesterone acetate, unlike norethisterone, directly increases R5 HIV-1 infection in human cervical explant tissue at physiologically relevant concentrations.避孕药醋酸甲羟孕酮与诺孕酯不同，它能在生理相关浓度下直接增加人体宫颈组织中 R5 HIV-1 的感染。

Sci Rep. 2019 Mar 13;9(1):4334. doi: 10.1038/s41598-019-40756-7.

HIV risk associated with serum medroxyprogesterone acetate levels among women in East and southern Africa.东非和南非妇女血清中醋酸甲羟孕酮水平与 HIV 风险的相关性。

AIDS. 2019 Mar 15;33(4):735-744. doi: 10.1097/QAD.0000000000002123.

Medroxyprogesterone acetate, unlike norethisterone, increases HIV-1 replication in human peripheral blood mononuclear cells and an indicator cell line, via mechanisms involving the glucocorticoid receptor, increased CD4/CD8 ratios and CCR5 levels.醋酸甲羟孕酮与炔诺酮不同，通过涉及糖皮质激素受体、增加 CD4/CD8 比值和 CCR5 水平的机制，增加了人类外周血单核细胞和指示细胞系中 HIV-1 的复制。

PLoS One. 2018 Apr 26;13(4):e0196043. doi: 10.1371/journal.pone.0196043. eCollection 2018.

Hormonal Contraception and HIV-1 Acquisition: Biological Mechanisms.激素避孕与 HIV-1 感染：生物学机制。

Endocr Rev. 2018 Feb 1;39(1):36-78. doi: 10.1210/er.2017-00103.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验